The absence of IL1R1 in T cells inhibits the production of IL‐17 and IL‐22, reducing the tumour‐induced inflammation, whereas in myeloid cells it increases the bacterial infiltration into the tumour tissue and triggers a pro‐tumorigenic inflammatory response.28 This evidence concerns the gene IL17A and neoplasm.